Stephenson Cancer Center At The University Of Oklahoma
At-home intervention has potential to enhance cancer care delivery, outcomes
CHICAGO — An intervention designed to provide supportive oncology care at home may enhance care delivery and improve outcomes for people receiving curative cancer treatment, according to findings presented at ASCO Annual Meeting.
Strategies can make adjustment to daylight saving time easier, mitigate health impacts
Daylight saving time has been a source of contention and debate since its introduction in 1918.
Novel drug delivery approach may protect against cisplatin-related hearing loss
A novel drug delivery construct may protect individuals against cisplatin-induced ototoxicity and associated hearing loss.
Oncologists play key role in diagnosing immune checkpoint inhibitor-induced myocarditis
Incidence of immune checkpoint inhibitor-induced myocarditis may increase as more patients receive immunotherapy. In this special report, Healio | HemOnc Today highlights how a multidisciplinary approach can reduce mortality through early recognition and prompt intervention.
Mirvetuximab soravtansine data ‘practice changing’ for subset of women with ovarian cancer
CHICAGO — Mirvetuximab soravtansine-gynx extended survival of women with platinum-resistant ovarian cancer and high folate receptor-alpha expression, according to a study that compared the agent with investigator’s choice of chemotherapy.
Simple hysterectomy safe for early-stage, low-risk cervical cancer
CHICAGO — Pelvic node dissection and simple hysterectomy appeared noninferior to radical hysterectomy at 3 years among women with early-stage, low-risk cervical cancer, according to data from the SHAPE study.
Timely intervention critical for major cardiac events after immune checkpoint therapy
CHICAGO — Patients and prescribers should be more aware of the potential for major adverse cardiac events after immune checkpoint inhibitor-based therapy, according to retrospective study results presented at ASCO Annual Meeting.